Skip to main content
. 2019 Dec 21;13(2):262–274. doi: 10.1016/j.tranon.2019.11.008

Figure 4.

Figure 4

CTL-based nasopharyngeal adoptive therapy. Reinfusion of EBV-antigens restricted cytotoxic T-lymphocytes (EBV-CTLs), following ex vivo activation of autologous T-cells in presence of IL-2 and lymphoblastoid cell lines (LCLs), represented by EBV-infected immortalized B-lymphocytes. PBMC: peripheral blood mononuclear cells; EBV: Epstein–Barr virus; LCL: lymphoblastoid cell lines; DC: dendritic cells; CTL: cytotoxic T-lymphocytes; IL-2: interleukin-2.